IntelliGenome Wins INVIMA Approval for CRISPR-TB Test
HOUSTON, Texas & BOGOTÁ, Colombia, June 29, 2026 IntelliGenome, Inc. has received sanitary registration approval from Colombia’s National Institute...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
HOUSTON, Texas & BOGOTÁ, Colombia, June 29, 2026 IntelliGenome, Inc. has received sanitary registration approval from Colombia’s National Institute...
BALTIMORE, Maryland, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of...
STAMFORD, Connecticut, June 30, 2026 Gainline Capital Partners has announced that its portfolio company M&M International, a leading manufacturer...
STOCKHOLM, Sweden, June 26, 2026 Sobi announced that it has received a Complete Response Letter (CRL) from the U.S....
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
Parsippany, New Jersey, USA | March 19, 2026 Embecta Corp. has announced a definitive agreement to acquire Owen Mumford...
MISSISSAUGA, ON – November 13, 2025 — Maple Leaf Foods has launched its new Mighty Protein Meat Sticks, a...
